Considering cocaine treatment in Switzerland means planning a clinical pathway in another health system. The important details include the actual setting, the professionals responsible for care, medication access, privacy arrangements, and the handoff back to the person’s usual clinicians. A private residence is only one part of that pathway.

This guide sets out practical questions for a prospective patient and their care team. Official clinical, Swiss regulatory, and provider sources were checked on October 18, 2026. It does not assume that traveling is necessary or that treatment in Switzerland produces better outcomes than appropriate care elsewhere.

State the clinical reason for considering Switzerland

Describe what the current treatment plan needs to achieve. The person may need assessment of recurring cocaine use, more coordinated psychiatric care, a period of residential structure, or a review of what has made earlier treatment difficult. These are different objectives that may call for different services.

Ask what a Swiss program would add beyond realistic local alternatives. If the answer is more individual therapy, a different care format, or better coordination, request details that can be compared. A preference for privacy is relevant, but it should not replace a clinical explanation of the proposed treatment.

SAMHSA’s stimulant-treatment guidance discusses behavioral treatment, engagement, recovery skills, and practical barriers to change. Use these subjects to ask how a proposed cocaine program would work. Source: SAMHSA TIP 33, practical treatment strategies.

Our local treatment or care abroad guide helps compare the whole episode, including what travel would add and which familiar supports would become less accessible.

Clarify the difference between residence and hospital care

Ask the provider to identify the actual level of care and what it can manage on site. A residential addiction program, a psychiatric hospital, and outpatient appointments with accommodation are not interchangeable. The person should understand which service is being offered before interpreting the setting’s amenities.

Tell the assessing team about other substances, prescribed medicines, recent mood or thought symptoms, physical health problems, and prior withdrawal experiences. The team needs a current account, including changes since the initial inquiry. Do not omit information because it may complicate admission.

If stabilization or another medical service is needed first, establish where it will occur and how the receiving program will reassess readiness. Ask who coordinates the transition and who pays for the additional service. Urgent needs should be addressed through suitable local care while an international plan is considered.

Check who will provide medical and psychiatric care

Request the names and roles of the professionals expected to treat the person. Identify the clinician responsible for medical decisions, the psychiatrist if one is involved, the principal therapist, and the person coordinating the plan. Ask which professionals are present routinely and which are available by appointment or on call.

The Swiss Federal Office of Public Health’s MedReg provides information on medical professionals, including qualifications, specializations, and professional authorization. Use the appropriate register for the professional’s role and check the named clinician rather than relying only on a program’s general team page. Source: FOPH MedReg information.

Registration information does not explain the treatment schedule. Ask how often the person would see each clinician and how the professionals discuss changes together. If the plan includes outside specialists, confirm their role, availability, language, and billing arrangements before assuming their work is included.

Check language access throughout the stay

Confirm the language in which the person can describe symptoms, ask about medicines, and participate in therapy. An initial conversation in English does not establish the language available during every clinical appointment. Ask about interpretation for outside consultations and how it would be arranged if an unexpected medical problem required attention.

Request understandable written information about the proposed care and any consent decisions. The discharge record should also be usable by the clinicians taking over at home. If translation is necessary, establish who organizes it, which documents are required, and whether the cost sits within the quoted program. This is especially useful when several professionals will receive different parts of the handoff.

Make the medication pathway explicit before travel

Create a list of every prescribed medicine, over-the-counter product, and supplement, including the generic name, formulation, actual regimen, and reason for use. Ask the current and receiving clinicians to review it together where appropriate. Include past problems with medicines and any recent change in actual use.

Swissmedic provides specific guidance for travelers carrying medicines containing controlled substances. Its current guidance uses a maximum thirty-day treatment-supply framework and explains documentation according to the route and country of origin. For a longer stay, arrange a Swiss clinician’s review and lawful continuation rather than assuming a larger supply can be carried. Source: Swissmedic controlled-medicine travel guidance.

Confirm the rules for the exact medicine with the relevant authorities, including any transit country. Swiss permission does not establish the rules for leaving the home country or returning to it. Do not rely on a prescription letter alone where a separate certificate or permission is required.

If treatment may change the regimen, ask whether the proposed medicine is available and can be prescribed at home. Identify the receiving prescriber and any necessary monitoring. A clinically sensible change in Switzerland still needs a practical continuation plan after departure.

Ask for privacy arrangements in operational terms

Swiss data-protection guidance treats health information as sensitive and explains professional secrecy, consent, and circumstances in which disclosure may occur. Privacy should therefore be discussed as a set of rules and practices, not a promise that information can never be shared. Source: Federal Data Protection and Information Commissioner: patient data disclosure.

Ask who receives information during assessment, treatment, billing, and discharge. Clarify what is shared with family, referring clinicians, laboratories, insurers, or outside specialists. If another person pays, discuss financial communication separately from permission to receive clinical details.

Tell the provider how to contact the patient discreetly and which channels are appropriate. Ask how records will be transferred to home clinicians and how the patient can obtain a usable summary. Privacy and continuity can be planned together through clear, informed arrangements.

Understand the proposed residential format

For example, THE BALANCE offers Zurich residential treatment subject to assessment and suitability. Its current program-fee page distinguishes Private from Semi-Private accommodation. Therapies and activities remain individual in both formats; the Semi-Private arrangement shares the residence, chef, and personal manager.

Executive Private in Zurich is CHF 90,000 per residential week, while Executive Semi-Private is CHF 60,000. Signature programs have different prices and inclusions. These are current published program figures, not a personal estimate or evidence that one package is clinically necessary. Source: https://thebalance.clinic/treatment-programs/cost/.

Ask how the specific proposal fits the cocaine-use pattern and any mental health needs. The provider’s suitability criteria distinguish voluntary residential care from acute hospital or other services that may be required when needs exceed the setting. Source: https://thebalance.clinic/treatment-programs/program-suitability-entry-criteria/.

Compare a complete estimate in the correct currency

Part of the plan What to confirm
Initial assessment Included or charged separately, with which professionals?
Residence or hospital Named site, care level, room arrangement, and period.
Additional clinical care Medicine, testing, specialist appointments, or outside services.
Travel Transport, clinical escort if needed, and changed bookings.
Continuing care Actual services, location limits, frequency, and fees.
Changes to the plan Extensions, transfers, early departure, and refund terms.

Keep Swiss francs separate from euro-denominated offers in other countries. A currency conversion can help budgeting, but it does not make differently defined packages equivalent. Ask the provider to explain the unit of charging and what happens if the clinical plan changes.

If insurance might contribute, seek confirmation for the actual program and circumstances. Do not infer coverage from international insurance branding or another patient’s experience. Preserve funds for care at home so the residential period does not exhaust the resources needed for continuity.

Coordinate the journey with clinical readiness

Discuss the proposed route, timing, support, and recent health changes with the treating team. A pre-travel medical discussion should consider the individual itinerary and current situation. CDC’s Yellow Book describes this individualized preparation rather than one universal travel checklist. Source: CDC pre-travel consultation guidance.

Ask what happens after a flight delay, missed connection, or change in symptoms before departure. Identify a named contact and a local route to care while waiting. If a clinical escort is needed, arrange it explicitly; ordinary airport collection does not establish medical supervision in transit.

Design the return before the admission begins

Identify the clinicians likely to provide ongoing addiction, psychiatric, and medical care after Switzerland. Ask whether they can accept the proposed responsibilities and what information they require. A discharge summary is more useful when the receiving professional is known and an appointment has been arranged.

Our returning-home guide addresses medication handoff, local treatment, and practical routines. Discuss how the person’s cocaine-related challenges will be worked on in the environment where they actually live, including work, relationships, and social contact.

The decision becomes clearer when the proposed Swiss stay has a defined purpose, an appropriate clinical team, understandable privacy and medication arrangements, and a credible next stage. Those details allow the person to evaluate the plan on its merits before committing to travel.

Sources and further reading

Found a detail that has changed? Tell the editorial team.